Russian, Western and Chinese vaccines are all in play in ex-Soviet Central Asia, with Uzbekistan’s neighbour Kazakhstan producing and distributing Russia’s Sputnik V jab and another neighbour Kyrgyzstan starting vaccinations with China’s Sinopharm last week.
But as in other parts of the world, rollout delays and vaccine scepticism have raised fears of an extended pandemic, which proved particularly brutal for the region’s countries last summer.
Uzbeks vaccinated on Thursday and interviewed by AFP had mostly opted for AstraZeneca instead of the vaccine developed by China’s Anhui Zhifei Longcom Biopharmaceutical Co.
“Now I will have to hope that everything goes well,” said Makhfuza Tuichibayeva, a retired doctor, who did not explain her choice of AstraZeneca, which Uzbekistan received over 600,000 doses of through the Covax programme.
Pavel Prosvirin, another pensioner, also picked AstraZeneca.
“So far I am feeling fine,” he told AFP.
The republic of 34 million people is targeting medics and citizens over 65 in its first wave of inoculations.
Retired university professor Malika Khadjayeva told AFP that she had opted to get a shot of the Chinese ZF-UZ-VAC 2001 vaccine that Uzbekistan expects to start producing in the coming months.
“I am up to date with what is happening,” she said, noting “very good results” the vaccine had produced in third stage trials carried out in Uzbekistan and other countries.
Khadjayeva said that she hoped Uzbekistan would avoid another summer like last year, when the coronavirus overwhelmed both its own health system and those of its neighbours.
“(Our) people have learned how to protect themselves and their close ones,” Khadjayeva said.
Uzbekistan’s health minister Abdukhakim Khadjibayev said authorities planned to vaccinate around four million people by the end of June.
An online poll by a state-endorsed non-profit organisation called Yukalish showed this month that 44 percent of more than 19,000 respondents did not intend to get vaccinated and showed Sputnik — also registered in Uzbekistan — as the preferred vaccine choice.
Next door, Kazakhstan’s president Kassym-Jomart Tokayev said Thursday that his country of 19 million people was “falling behind”, with only 47,000 people fully vaccinated against coronavirus since the rollout began at the start of last month.
“The reason for this situation is simple — lack of vaccines,” Tokayev said.
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.